Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. Februar 2018 08:30 ET | Quelle: Globus Medical

Globus Medical Schedules Fourth Quarter and Full Year 2017 Earnings Release and Conference Call

AUDUBON, Pa., Feb. 09, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full...
08. Februar 2018 18:30 ET | Quelle: Xeris Pharmaceuticals, Inc.

FDA Grants Orphan Drug Designation (ODD) for Xeris Pharmaceuticals' Ready-to-Use Glucagon for the Treatment of Hyperinsulinemic Hypoglycemia (HH). Results from Phase 2a Study in Post-Bariatric Hypoglycemia, Associated with HH, Published.

Chicago, IL, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”), a specialty pharmaceutical company leveraging its novel technology platforms to develop and...
08. Februar 2018 08:30 ET | Quelle: Arbutus Biopharma Corporation

Arbutus Consolidates HBV Business Around Warminster, PA Site

VANCOUVER, British Columbia and WARMINSTER, Pa., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions...
07. Februar 2018 15:00 ET | Quelle: Virta Health

Virta Health's Treatment for Sustained Type 2 Diabetes Reversal Provides New Hope for Chronic Disease Patients

San Francisco, CA, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Virta Health, the first company with a clinically-proven treatment to safely and sustainably reverse type 2 diabetes and other chronic metabolic...
07. Februar 2018 07:05 ET | Quelle: Myriad Genetics, Inc.

Myriad’s myRisk® Hereditary Cancer Test Finds More Than 12 Percent of Men with Prostate Cancer Carry an Inherited Genetic Mutation

SALT LAKE CITY, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that results from a large...
06. Februar 2018 09:00 ET | Quelle: NewLink Genetics Corporation

NewLink Genetics to Participate in Upcoming Investor Conferences

AMES, Iowa, Feb. 06, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced today that the company will participate in the following investor conferences: BIO CEO &...
06. Februar 2018 08:00 ET | Quelle: Fibrocell Science Inc

Fibrocell to Present at 20th Annual BIO CEO & Investor Conference

EXTON, Pa., Feb. 06, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue...
05. Februar 2018 08:00 ET | Quelle: Fibrocell Science Inc

Fibrocell Announces Submission of Investigational New Drug Application for FCX-013 for the Treatment of Moderate to Severe Localized Scleroderma

EXTON, Pa., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective...
02. Februar 2018 09:45 ET | Quelle: Sunset Island Group, Inc.

Sunset Island Group Provides Corporate Update

SALINAS, Calif., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- SUNSET ISLAND GROUP, INC. (OTCQB:SIGO) is pleased to provide the following update. Licensing: Company has received its...
31. Januar 2018 12:00 ET | Quelle: LogixHealth

LogixHealth Releases Review of 2018 Physician Fee Schedule Final Rule

BEDFORD, Mass., Jan. 31, 2018 (GLOBE NEWSWIRE) -- LogixHealth has released its 2018 ED Physician Update, a comprehensive review of Medicare’s 2018 Physician Fee Schedule final rule as it relates to...

Vorherige Seite

Nächste Seite